 |
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Here is a comparison of NFP37-funded research
in Phase A and Phase B.
The sum of the different categories is larger than the total number
of grants because some projects belong to more than one
category.
|
GENERALITIES |
PHASE A |
PHASE B |
|
Submissions |
56 |
26 |
|
Total requested amount |
32 Mio Sfr |
9 Mio Sfr |
|
Granted amount |
7.6 Mio Sfr |
6.2 Mio Sfr |
|
|
PHASE A |
PHASE B |
|
GEOGRAPHICAL DISTRIBUTION |
|
|
|
BASEL |
2 |
3 |
|
BERN |
3 |
3 |
|
FRIBOURG |
1 |
2 |
|
GENEVA |
5 |
5 |
|
LAUSANNE |
5 |
6 |
|
ZUERICH |
5 |
4 |
|
. |
|
|
|
DISEASE ORIENTATION |
|
|
|
Cancer |
8 |
9 |
|
Hereditary disorders |
2 |
4 |
|
Infectious diseases |
1 |
2 |
|
Acquired or degenerative disorders |
2 |
6 |
|
Vector development (no disease orientation) |
5 |
2 |
|
. |
|
|
|
RESEARCH LEVEL |
|
|
|
Fundamental research |
12 |
6 |
|
Preclinical research (animal models) |
5 |
10 |
|
Clinical research phase I |
2 |
5 |
|
Clinical research Phase II |
0 |
1 |
|
Clinical research Phase III |
0 |
0 |
|
Ethical/social aspects |
1 |
1 |
|
Fellowships |
3 |
2 |
|
|
|
|
|
|
|
|
Click here for details on the individual phase B projects.
Click here for details on the individual phase A projects
|
|
|
|
|
|
